Skip to main content
ISSCR 2024 Annual Meeting Main banner
Icon Legend
Back

Filipe Pereira, PhD (he/him/his)

Lund University, Sweden

Filipe Pereira is a Professor in Molecular Medicine at Lund University in Sweden, group leader of the Cell Reprogramming in Hematopoiesis and Immunity Laboratory and co-founder of Asgard Therapeutics. Dr. Pereira is recognized for his work at the interface of cellular reprogramming and immunology and for fostering the development of reprogramming-based immunotherapies. Dr. Pereira received his Ph.D. at Imperial College London and did his postdoctoral training at the Icahn School of Medicine in NYC. His research group at Lund University has uncovered new mechanisms underlying hematopoietic reprogramming and definitive hematopoiesis specification. He also pioneered cellular reprogramming approaches in immunology by inducing dendritic cells from fibroblasts and cancer cells. This conceptual shift opened exciting opportunities to develop new modalities for cancer immunotherapy based on cellular reprogramming.

Presentation(s):